Does hydroxyzine interact with selective serotonin reuptake inhibitors (SSRIs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hydroxyzine and SSRIs: Interaction Profile

Yes, hydroxyzine does interact with SSRIs, primarily through two mechanisms: additive QT prolongation risk and potential enhancement of CNS depressant effects, but these interactions can be managed with appropriate monitoring and do not represent an absolute contraindication to concurrent use.

Key Interaction Mechanisms

QT Prolongation Risk

The most clinically significant interaction involves cardiac conduction effects. Hydroxyzine can cause QT prolongation and has been associated with Torsade de Pointes in post-marketing surveillance 1. When combined with SSRIs—particularly citalopram, escitalopram, and fluoxetine—the risk of QT prolongation increases through additive effects 2, 1.

  • Citalopram and escitalopram carry the highest risk among SSRIs, with dose-related QT prolongation documented at doses exceeding 40 mg/day 2, 3
  • Fluoxetine, paroxetine, and sertraline have moderate QT effects through CYP2D6 interactions 2
  • Sertraline appears safest for cardiovascular concerns among SSRIs 3

CNS Depression

Hydroxyzine potentiates CNS depressants, and the FDA label explicitly warns about this interaction 1. While SSRIs themselves cause somnolence 3, the combination with hydroxyzine's sedating antihistamine effects can produce additive drowsiness and cognitive impairment.

Clinical Management Algorithm

When prescribing hydroxyzine with SSRIs:

  1. Baseline cardiac assessment if risk factors present:

    • Obtain ECG in patients with pre-existing heart disease, electrolyte imbalances, congenital long QT syndrome, family history of long QT, recent MI, uncompensated heart failure, or bradyarrhythmias 1
    • Check electrolytes (potassium, magnesium) before initiation
  2. SSRI selection matters:

    • Prefer sertraline if cardiac concerns exist 3
    • Avoid citalopram/escitalopram in patients with QT risk factors or when doses exceed 40 mg/day 2, 3
    • Consider that fluvoxamine has extensive CYP450 interactions that may complicate polypharmacy 2
  3. Dosing strategy:

    • Start hydroxyzine at low doses when combined with SSRIs 1
    • Monitor closely in first 24-48 hours after initiation or dose changes 2
    • Reduce hydroxyzine dose if excessive sedation occurs 1
  4. Patient counseling:

    • Warn about additive drowsiness and impaired driving ability 1
    • Advise against alcohol and other CNS depressants 1
    • Educate on symptoms of cardiac arrhythmia (palpitations, syncope, dizziness)

Important Caveats

This combination is NOT contraindicated and is actually used clinically. Recent evidence shows SSRIs combined with hydroxyzine were effective in treating anxiety-related conditions like ARFID, with hydroxyzine specifically helping patients with high pre- and post-meal anxiety 4. The combination showed similar improvements to SSRI monotherapy, suggesting hydroxyzine can be safely added when needed 4.

Avoid confusing this with serotonin syndrome risk: The guidelines mention caution with combining serotonergic drugs and list chlorpheniramine (another antihistamine) as requiring caution 2. However, hydroxyzine is primarily an H1-antihistamine with antiserotonergic properties 5, not a serotonergic agent. The interaction concern is QT prolongation and CNS depression, not serotonin syndrome.

Elderly patients require special attention: Both medications cause increased sedation, confusion, and fall risk in older adults 1. Start with the lowest doses and monitor closely, as elderly patients have decreased renal function affecting hydroxyzine clearance 1.

Monitor for anticholinergic burden: Paroxetine has more anticholinergic effects than other SSRIs 3, and hydroxyzine also has anticholinergic properties 5. This combination may increase cognitive impairment, particularly in elderly patients.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.